EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

ASSESSMENT OF HIGH-RISK GROUP FOR IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) DEVELOPMENT AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS/ ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV/AIDS) IN NEPAL

Mishra S. K., Napit R., Bastola A. and Manandhar K. D.*

ABSTRACT

Background: Immune Reconstitution Inflammatory Syndrome (IRIS) a clinical condition which is a side effect of Anti-Retroviral Therapy (ART) due to rapid recovery of Immune system leading to adverse effects. So far, Predicting IRIS have not been difficult but recently some research showed it can be narrowed down to the high-risk group on the basis of cluster differentiation (CD4+ & CD8+) level and of CD4+ /CD8+ ratio. Methods: The study was carried out at National Public Health laboratory, the apex laboratory of Government of Nepal; and Sukraraj Tropical Infectious Disease Hospital (STIDH). Includes 1060 HIV infected people and Cluster Differentiation (CD) profile was enumerated by Fluorescent Activated Cell Sorting (FACS) caliber machine. All the data were collected systematically and arranged in a tabular form and statistically analyzed using Graph Pad Prism ver7.0 to check the characteristics of population along with other statistical tests. Results: The study was carried out with 1006 HIV infected patients consisting of 60.7% male and 39.2% female. CD4+/CD8+ ratio was taken as major predictor and tested, CD4+/CD8+ ratio value was divided into four group to simplify analysis (>1.5, 0.3-1.5, 0.15-0.3 and <0.15). 75 percentiles of people had CD4+/CD8+ ratio value of below 0.5 indicating poor immune status. Out of 1006 HIV patients included in this study only 44 showed IRIS within six months of starting ART and all of them had CD4+/CD8+ ratio of below 0.15 (considered as high-risk group in this study). Also, chi-square test showed positive association between IRIS cases and CD4+/CD8+ ratio along with sex and Age. All the IRIS confirmed cases lied in the high-risk group and were indicated by CD4+/CD8+ ratio value before starting ART. Conclusions: More than 75 percentiles of people living with HIV/AIDS (PLHIV) showed abnormal CD4+/CD8+ratio of below 0.5. The incidence of IRIS among ART initiator PLHIV was identified as High-Risk group using CD4+/CD8+ ratio more accurately in Nepalese people. Hence, CD4+/CD8+ ratio measurement will help narrow down high-risk group of IRIS cases among PLHIV initiating ART. Treatment of IRIS will remain a clinical challenge due to the variety of clinical presentations and the presence of multiple pathogens capable of causing the syndrome. Patients at greatest risk for the development of serious IRIS events, a low CD4+/CD8+ ratio of <0.15, should be screened to exclude an active or subclinical infection with important opportunistic.

Keywords: IRIS, CD4+, CD8+, HIV, Nepal, PLHIV


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here